2 recruiting, 1 completed, 1 terminated, 1 unknown. 2 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Sensory System Agents: new trials by email Literature Review of Sensory System Agents trials Research Report on Sensory System Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nebulized Ketamine for the Treatment of Major Depressive Disorder nebulized ketamine, nebulized midazolam - Severe Depression, Moderate Depression | Phase 3 | Recruiting | Theresa Jacob, PhD, MPH | 40 | 2024-10-16 | 2026-04-24 |
| Natural History of Depression, Bipolar Disorder and Suicide Risk Behavioral Symptoms, Suicide | Recruiting | National Institute of Mental Health (NIMH) | 500 | 2024-09-09 | 2026-10-01 | |
| Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression VTS-K - Treatment Resistant Depression, Major Depressive Disorder | Phase 4 | Completed | Theresa Jacob, PhD, MPH | 15 | 2022-12-06 | 2026-04-21 |
| Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM CYNK001-IV, CYNK001-IT - Astrocytoma, Grade IV, Giant Cell Glioblastoma | Phase 1 | Terminated | Celularity Incorporated | 3 | 2020-10-01 | 2022-08-10 |
| Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma CYNK-001 - Multiple Myeloma, Neoplasm, Plasma Cell | Phase 1 | Unknown | Celularity Incorporated | 29 | 2020-05-12 | 2023-02-16 |
Depression (3) · Depressive Disorder, Major (2) · Depressive Disorder, Treatment-Resistant (2) · Agnosia (1) · Behavioral Symptoms (1) · Bipolar Disorder (1) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Depressive Disorder (1) · Glioblastoma (1) · Hematologic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1)
Behavior (3) · Behavioral Symptoms (2) · Mental Disorders (2) · Mood Disorders (2) · Pathological Conditions, Signs and Symptoms (2) · Astrocytoma (1) · Bipolar and Related Disorders (1) · Depressive Disorder (1) · Glioma (1) · Hemic and Lymphatic Diseases (1) · Lymphatic Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1)
Ketamine (2) · Aspirin (1) · Midazolam (1)
Celularity Incorporated (2) · Theresa Jacob, PhD, MPH (2) · National Institute of Mental Health (NIMH) (1)
United States (5)
Theresa Jacob, PhD, MPH (2) · Adrian Kilcoyne, MD (1) · Elizabeth D Ballard, Ph.D. (1) · Sharmila Koppisetti, MD (1)